Biocon Limited has informed the Exchange about Schedule of meet

Board & Shareholder Meetings View source PDF

BIOCON · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

-1.6%1-day move

₹433.75

prior close

₹432.20

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

+1.0+1.2+1.3+0.9-1.6-4.0-5.0-4.3-4.7-3.8-4.2-4.5——

Up moveDown movePending

AI summary

Biocon Limited has notified the stock exchanges about a scheduled group meeting with analysts and institutional investors on June 3, 2026, as part of the Investec US Pharma & Healthcare Bus Tour in the USA. The filing is made under SEBI Listing Regulation 30(6) which requires disclosure of investor meetings. The company has explicitly stated it will not disclose any Unpublished Price Sensitive Information (UPSI) during the meeting. This is a routine regulatory disclosure to maintain transparency about management's investor engagement schedule.

Likely market impact

This is a standard investor relations disclosure with no immediate impact on shareholders. It demonstrates active investor engagement but contains no material information, guidance, or price-sensitive details.